//
Elisa Lancini
Franziska Bartl
Lena Haag
Maren Rühling
Nicholas J. Ashton
Henrik Zetterberg
Emrah Duzel
Dorothea Hämmerer
Matthew Betts
Institute of Psychiatry, Psychology & Neuroscience, King's College London
University Hospital Regensburg
King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute
Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden
The Wellcome Trust Centre for Neuroimaging, University College London
Institute for Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London
Institute of Cognitive Neuroscience, University College, London, United Kingdom
Otto-von-Guericke University
German Center for Neurodegenarative Diseases (DZNE)
Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden
UK Dementia Research Institute
Institute of Physiology and Neuroscience, University of Gothenburg
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden
Center for Behavioral Brain Science (CBBS)
NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation
Germany
United Kingdom
N/A
N/A
N/A
3-Methoxy-4-hydroxyphenylglycol
Cerebrospinal fluid
Norepinephrine topical
N/A
N/A
NA
N/A
N/A
N/A